Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TAO SynergiesTAOX -4.07%30 Equity-to-Asset is 0.82 as of Jun. 2026, which is 10% below its 10-year median of 0.91. GuruFocus rates TAOX with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 809 Capital Markets companies, TAO Synergies ranks better than 75.03% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. TAO Synergies's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $17.29 Mil. TAO Synergies's Total Assets for the quarter that ended in Jun. 2026 was $21.10 Mil.
Therefore, TAO Synergies's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.82.
The historical rank and industry rank for TAO Synergies's Equity-to-Asset or its related term are showing as below:
TAOX'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.38 Med: 0.91 Max: 0.98
Current: 0.82
During the past 7 years, the highest Equity to Asset Ratio of TAO Synergies was 0.98. The lowest was 0.38. And the median was 0.91.
TAOX's Equity-to-Asset is ranked better than 75.03% of 809
companies
in the Capital Markets industry
Industry Median: 0.5
vs TAOX: 0.82
TAO Synergies (NAS:TAOX) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
TAO Synergies Equity-to-Asset Related Terms
TAO Synergies Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for TAO Synergies's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TAOX vs FLD, ATCH, MDBH: Equity-to-Asset Comparison
For the Capital Markets subindustry, TAO Synergies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TAO Synergies Equity-to-Asset vs Capital Markets Industry
For the Capital Markets industry and Financial Services sector, TAO Synergies's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where TAO Synergies's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
TAO Synergies's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TAO Synergies (TAOX) has a Equity-to-Asset of 0.82 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on TAO Synergies and its competitors. This is 10% below median its historical median of 0.91. Over the past decade, TAO Synergies' Equity-to-Asset has ranged from 0.38 to 0.98. According to the industry distribution chart, TAO Synergies ranks #202 out of 809 companies in the Capital Markets industry, placing it in the top 25%.
Is TAO Synergies' Equity-to-Asset too high?
TAO Synergies' current Equity-to-Asset of 0.82 is 10% below median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 0.98. The Capital Markets industry median Equity-to-Asset is 0.50. TAO Synergies' value of 0.82 is 64% above this industry median. Based on the distribution chart, TAO Synergies ranks #202 out of 809 companies in the Capital Markets industry, which is in the top quartile — a strong position relative to peers. Overall, TAO Synergies has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does TAO Synergies' Equity-to-Asset compare to FLD and ATCH?
According to the Capital Markets industry distribution chart, TAO Synergies ranks #202 out of 809 companies for Equity-to-Asset. This places TAO Synergies in the top 25% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.50. TAO Synergies' value of 0.82 is 64% above this benchmark. Historically, TAO Synergies' own Equity-to-Asset has ranged from 0.38 to 0.98 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 0.50, TAO Synergies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Capital Markets company?
The median Equity-to-Asset among Capital Markets companies is 0.50, based on 809 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TAO Synergies's current Equity-to-Asset of 0.82 is 64% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on TAO Synergies and its competitors. For the Capital Markets industry, the median Equity-to-Asset is 0.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TAO Synergies's current Equity-to-Asset is 0.82, which is 10% below median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TAO Synergies stock overvalued right now?
TAO Synergies (TAOX) has a current Equity-to-Asset of 0.82. The current Equity-to-Asset is 0.82, which is 10% below median its 10-year median of 0.91 and 64% above the Capital Markets industry median of 0.50. TAO Synergies' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For TAO Synergies (TAOX), the current Equity-to-Asset is 0.82 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
30GF Score
Get the complete analysis for TAOX
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TAOX has been successfully added to your 
